Michael James Overman (Michael J Overman, Michael Overman)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 48

Top Topics

Endoscopic Submucosal Dissection

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Rodabe Amaria, Anne Knisely, David Vining, Scott Kopetz, Michael James Overman, Milind Javle, Mara B Antonoff, Ching-Wei D Tzeng, Robert A Wolff, Shubham Pant, Kathryn Lito, Kelly Rangel, Bryan Fellman, Ying Yuan, Karen H Lu, Donastas Sakellariou-Thompson, Cara L Haymaker, Marie-Andrée Forget, Patrick Hwu, Chantale Bernatchez, Amir A Jazaeri
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Nicholas J Hornstein, Mohammad A Zeineddine, Betul Beyza Gunes, Andrew J Pellatt, Mark Knafl, Haifeng Zhu, Anneleis F Willett, Abdelrahman M G Yousef, Suyu Liu, Ryan Sun, P Andrew Futreal, Scott E Woodman, Melissa W Taggart, Michael James Overman, Daniel M Halperin, Kanwal P S Raghav, John Paul Shen
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma. Cancer research communications 4 (5) (2024)
Michael James Overman, Fabio Gelsomino, Massimo Aglietta, Mark Wong, Maria Luisa Limon Miron, Gregory Leonard, Pilar García-Alfonso, Andrew G Hill, Antonio Cubillo Gracian, Eric Van Cutsem, Bassel El-Rayes, Stephen M McCraith, Beilei He, Ming Lei, Sara Lonardi
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. Journal for immunotherapy of cancer 12 (5) (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary endpoint utilization and publication rate among phase III oncology trials. Cancer research communications (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Nicholas J Hornstein, Mohammad A Zeineddine, Betul Beyza Gunes, Andrew J Pellatt, Mark Knafl, Haifeng Zhu, Anneleis F Willett, Abdelrahman M G Yousef, Suyu Liu, Ryan Sun, P Andrew Futreal, Scott E Woodman, Melissa W Taggart, Michael James Overman, Daniel M Halperin, Kanwal P S Raghav, John Paul Shen
Efficacy and safety of atezolizumab and bevacizumab in appendiceal adenocarcinoma. Cancer research communications (2024)
Nicholas J Hornstein, Mohammad A Zeineddine, Betul Beyza Gunes, Andrew J Pellatt, Mark Knafl, Haifeng Zhu, Anneleis F Willett, Abdelrahman M G Yousef, Suyu Liu, Ryan Sun, P Andrew Futreal, Scott E Woodman, Melissa W Taggart, Michael James Overman, Daniel M Halperin, Kanwal P S Raghav, John Paul Shen
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma. Cancer research communications 4 (5) (2024)
Michael James Overman, Fabio Gelsomino, Massimo Aglietta, Mark Wong, Maria Luisa Limon Miron, Gregory Leonard, Pilar García-Alfonso, Andrew G Hill, Antonio Cubillo Gracian, Eric Van Cutsem, Bassel El-Rayes, Stephen M McCraith, Beilei He, Ming Lei, Sara Lonardi
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. Journal for immunotherapy of cancer 12 (5) (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Nicholas J Hornstein, Mohammad A Zeineddine, Betul Beyza Gunes, Andrew J Pellatt, Mark Knafl, Haifeng Zhu, Anneleis F Willett, Abdelrahman M G Yousef, Suyu Liu, Ryan Sun, P Andrew Futreal, Scott E Woodman, Melissa W Taggart, Michael James Overman, Daniel M Halperin, Kanwal P S Raghav, John Paul Shen
Efficacy and safety of atezolizumab and bevacizumab in appendiceal adenocarcinoma. Cancer research communications (2024)
Michael James Overman, Fabio Gelsomino, Massimo Aglietta, Mark Wong, Maria Luisa Limon Miron, Gregory Leonard, Pilar García-Alfonso, Andrew G Hill, Antonio Cubillo Gracian, Eric Van Cutsem, Bassel El-Rayes, Stephen M McCraith, Beilei He, Ming Lei, Sara Lonardi
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. Journal for immunotherapy of cancer 12 (5) (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Rodabe Amaria, Anne Knisely, David Vining, Scott Kopetz, Michael James Overman, Milind Javle, Mara B Antonoff, Ching-Wei D Tzeng, Robert A Wolff, Shubham Pant, Kathryn Lito, Kelly Rangel, Bryan Fellman, Ying Yuan, Karen H Lu, Donastas Sakellariou-Thompson, Cara L Haymaker, Marie-Andrée Forget, Patrick Hwu, Chantale Bernatchez, Amir A Jazaeri
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Michael James Overman, Fabio Gelsomino, Massimo Aglietta, Mark Wong, Maria Luisa Limon Miron, Gregory Leonard, Pilar García-Alfonso, Andrew G Hill, Antonio Cubillo Gracian, Eric Van Cutsem, Bassel El-Rayes, Stephen M McCraith, Beilei He, Ming Lei, Sara Lonardi
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. Journal for immunotherapy of cancer 12 (5) (2024)
Andrew L Coveler, Matthew J Reilley, Mark M Zalupski, Teresa Macarulla, Christos Fountzilas, Mariano Ponz-Sarvisé, Adnan Nagrial, Nataliya V Uboha, Sophia Frentzas, Michael James Overman, Anne M Noonan, Wells A Messersmith, Nick Pavlakis, Niharika B Mettu, Ina Bisha, Ying Wang, Paul Smith, Elina Murtomaki, Agata A Bielska, Veronique Bragulat, Zachary A Cooper, Rakesh Kumar, David R Spigel
A Phase 1b/2 Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rodabe Amaria, Anne Knisely, David Vining, Scott Kopetz, Michael James Overman, Milind Javle, Mara B Antonoff, Ching-Wei D Tzeng, Robert A Wolff, Shubham Pant, Kathryn Lito, Kelly Rangel, Bryan Fellman, Ying Yuan, Karen H Lu, Donastas Sakellariou-Thompson, Cara L Haymaker, Marie-Andrée Forget, Patrick Hwu, Chantale Bernatchez, Amir A Jazaeri
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Rodabe Amaria, Anne Knisely, David Vining, Scott Kopetz, Michael James Overman, Milind Javle, Mara B Antonoff, Ching-Wei D Tzeng, Robert A Wolff, Shubham Pant, Kathryn Lito, Kelly Rangel, Bryan Fellman, Ying Yuan, Karen H Lu, Donastas Sakellariou-Thompson, Cara L Haymaker, Marie-Andrée Forget, Patrick Hwu, Chantale Bernatchez, Amir A Jazaeri
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Rodabe Amaria, Anne Knisely, David Vining, Scott Kopetz, Michael James Overman, Milind Javle, Mara B Antonoff, Ching-Wei D Tzeng, Robert A Wolff, Shubham Pant, Kathryn Lito, Kelly Rangel, Bryan Fellman, Ying Yuan, Karen H Lu, Donastas Sakellariou-Thompson, Cara L Haymaker, Marie-Andrée Forget, Patrick Hwu, Chantale Bernatchez, Amir A Jazaeri
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. Journal for immunotherapy of cancer 12 (2) (2024)
Praveen Vikas, Hans Messersmith, Carolyn Compton, Lynette M Sholl, Russell R Broaddus, Anjee Davis, Maria Estevez-Diz, Rohan Garje, Panagiotis A Konstantinopoulos, Aliza Leiser, Anne M Mills, Barbara S Norquist, Michael James Overman, Davendra P S Sohal, Richard C Turkington, Tyler Johnson
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Praveen Vikas, Hans Messersmith, Carolyn Compton, Lynette M Sholl, Russell R Broaddus, Anjee Davis, Maria Estevez-Diz, Rohan Garje, Panagiotis A Konstantinopoulos, Aliza Leiser, Anne M Mills, Barbara S Norquist, Michael James Overman, Davendra P S Sohal, Richard C Turkington, Tyler Johnson
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kaysia Ludford, Won Jin Ho, Jane V Thomas, Kanwal P S Raghav, Mariela Blum Murphy, Nicole D Fleming, Michael S Lee, Brandon G Smaglo, Y Nancy You, Matthew M Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, Benny Johnson, Eduardo Vilar, Arvind N Dasari, Sarah M Shin, Alexei Hernandez, Xuan Yuan, Hongqui Yang, Wai Chin Foo, Wei Qiao, Dipen Maheshbhai Maru, Edmund S Kopetz, Michael James Overman
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Stefania Napolitano, Aparna Raj Parikh, Jason T Henry, Christine M Parseghian, Jason Willis, Kanwal P S Raghav, Van Karlyle Morris, Benny Johnson, Bryan K Kee, Arvind N Dasari, Michael James Overman, Raja Luthra, Leylah M Drusbosky, Ryan B Corcoran, Edmund S Kopetz, Ryan Sun
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing. JCO precision oncology 7 (2023)
Julia Dansby, Aditya More, Mohammad Zeineddine, Abdelrahman Yousef, Alisha Bent, Farshid Dayyani, Robert A Wolff, Michael James Overman, John Paul Shen
Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma. The oncologist (2023)
Kaysia Ludford, Won Jin Ho, Jane V Thomas, Kanwal P S Raghav, Mariela Blum Murphy, Nicole D Fleming, Michael S Lee, Brandon G Smaglo, Y Nancy You, Matthew M Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, Benny Johnson, Eduardo Vilar, Arvind N Dasari, Sarah M Shin, Alexei Hernandez, Xuan Yuan, Hongqui Yang, Wai Chin Foo, Wei Qiao, Dipen Maheshbhai Maru, Edmund S Kopetz, Michael James Overman
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Johanna Bendell, Patricia LoRusso, Michael James Overman, Anne M Noonan, Dong Wan Kim, John H Strickler, Sang-We Kim, Stephen Clarke, Thomas J George, Peter S Grimison, Minal Barve, Manik Amin, Jayesh Desai, Trisha Michel Wise-Draper, Steven Eck, Yu Jiang, Anis A Khan, Yuling Wu, Philip Martin, Zachary A Cooper, Nairouz Elgeioushi, Nancy Mueller, Rakesh Kumar, Sandip Pravin Patel
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors. Cancer immunology, immunotherapy : CII (2023)
Praveen Vikas, Hans Messersmith, Carolyn Compton, Lynette M Sholl, Russell R Broaddus, Anjee Davis, Maria Estevez-Diz, Rohan Garje, Panagiotis A Konstantinopoulos, Aliza Leiser, Anne M Mills, Barbara S Norquist, Michael James Overman, Davendra P S Sohal, Richard C Turkington, Tyler Johnson
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria Serpas Higbie, Kanwal P S Raghav, Benny Johnson, Arvind N Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Edmund S Kopetz, Michael James Overman, Van Karlyle Morris
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer research communications 3 (12) (2023)
Anaeze Chidiebele Offodile, Domenica Delgado, Yu-Li Lin, Danielle Geyen, Christopher J Miller, Sanchita Jain, Janice P Finder, Sanjay S Shete, Frank V Fossella, Michael James Overman, Susan K Peterson
Integration of Remote Symptom and Biometric Monitoring Into the Care of Adult Patients With Cancer Receiving Chemotherapy-A Decentralized Feasibility Pilot Study. JCO oncology practice (2023)
Jason A Willis, Michael James Overman
Inducing Hypermutability to Promote Anti-PD-1 Therapy Response. Cancer discovery 12 (7) (2022)
Anna Morena D'Alise, Nadia Brasu, Carlo De Intinis, Guido Leoni, Valentina Russo, Francesca Langone, Denis Baev, Elisa Micarelli, Luca Petiti, Simone Picelli, Marwan G Fakih, Dung T Le, Michael James Overman, Anthony Frank Shields, Katrina S Pedersen, Manish A Shah, Sarbajit Mukherjee, Thea Faivre, Patricia Delaite, Elisa Scarselli, Luigia Pace
Adenoviral-based vaccine promotes neoantigen-specific CD8 + T cell stemness and tumor rejection. Science translational medicine 14 (657) (2022)
Victoria Serpas Higbie, Jane E Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind N Dasari, Kerri Mola-Rudd, Van Karlyle Morris, Robert A Wolff, Kanwal P S Raghav, Ryan Huey, Christine M Parseghian, Jason A Willis, Edmund S Kopetz, Michael James Overman, Benny Johnson
Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience. The oncologist 27 (11) (2022)
Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, Ganiraju C Manyam, Shailesh M Advani, Riham Katkhuda, Anuj Verma, Michael Lam, Jason Willis, John Paul Shen, Jeffrey Morris, Jennifer S Davis, Jonathan M Loree, Hey Min Lee, Jaffer A Ajani, Dipen Maheshbhai Maru, Michael James Overman, Scott Kopetz
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2021)
Kanwal Raghav, Suyu Liu, Michael James Overman, Anneleis F Willett, Mark Knafl, Szu-Chin Fu, Anais Malpica, Seema Prasad, Richard E Royal, Christopher P Scally, Paul F Mansfield, Ignacio I Wistuba, Andrew P Futreal, Dipen Maheshbhai Maru, Luisa M Solis Soto, Edwin R Parra Cuentas, Honglei Chen, Pamela Villalobos, Anuj Verma, Armeen Mahvash, Patrick Hwu, Patricia Cortazar, Edward McKenna, Cindy Yun, Shannon Dervin, Katja Schulze, Walter C Darbonne, Ajaykumar C Morani, Scott Kopetz, Keith F Fournier, Scott E Woodman, James C Yao, Gauri R Varadhachary, Daniel M Halperin
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer discovery 11 (11) (2021)
Preeti Kanikarla Marie, Cara L Haymaker, Edwin Roger Parra Cuentes, Young Uk Kim, Rossana Lazcano, Swati Gite, Daniele Lorenzini, Ignacio I Wistuba, Rebecca S Slack Tidwell, Xiaofei Song, Wai Chin Foo, Dipen Maheshbhai Maru, Yun Shin Chun, Andy Futreal, Bryan Kee, David Menter, Luisa Maren Solis Soto, Ching-Wei D Tzeng, Christine M Parseghian, Kanwal Raghav, Van Karlyle Morris, Chia-Chi Chang, Robert Jenq, Alda L Tam, Chantale Bernatchez, Scott Kopetz, Jean-Nicholas Vauthey, Michael James Overman
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Kanwal Raghav, Hyunsoo Hwang, Alexandre A A Jácome, Eric Bhang, Anneleis Willett, Ryan W Huey, Nishat P Dhillon, Jignesh Modha, Brandon G Smaglo, Aurelio Matamoros, Jeannelyn S Estrella, Justin Jao, Michael James Overman, Xuemei Wang, F Anthony Greco, Jonathan M Loree, Gauri R Varadhachary
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Katrina S Pedersen, Nathan R Foster, Michael James Overman, Patrick M Boland, Sunnie S Kim, Kathryn A Arrambide, Brandy L Jaszewski, Tanios Bekaii-Saab, Rondell P Graham, Jack Welch, Richard H Wilson, Robert R McWilliams
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Kushal T Kadakia, Malke Asaad, Erica Adlakha, Michael James Overman, Cristina M Checka, Anaeze Chidiebele Offodile
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions. JCO clinical cancer informatics 5 (2021)
Heinz-Josef Lenz, Eric Van Cutsem, Maria Luisa Limon, Ka Yeung Mark Wong, Alain Hendlisz, Massimo Aglietta, Pilar García-Alfonso, Bart Neyns, Gabriele Luppi, Dana Backlund Cardin, Tomislav Dragovich, Usman Shah, Sandzhar Abdullaev, Joseph Gricar, Jean-Marie Ledeine, Michael James Overman, Sara Lonardi
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Jonathan M Loree, Yucai Wang, Muddassir A Syed, Alexey V Sorokin, Oluwadara Coker, Joanne Xiu, Benjamin A Weinberg, Ari M VanderWalde, Anteneh A Tesfaye, Victoria M Raymond, Benjamin Miron, Gabi Tarcic, Ori Zelichov, Russell R Broaddus, Patrick Kwok Shing Ng, Kang Jin Jeong, Yiu Huen Tsang, Gordon B Mills, Michael James Overman, Axel Grothey, John L Marshall, Scott Kopetz
Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
Van Karlyle Morris, Rajyalakshmi Luthra, Yusha Liu, Dzifa Y Duose, Wonyul Lee, Neelima G Reddy, Justin Windham, Huiqin Chen, Zhimin Tong, Baili Zhang, Wei Wei, Manyam Ganiraju, Bradley M Broom, Hector A Alvarez, Alicia Mejia, Omkara Veeranki, Mark J Routbort, Michael James Overman, David Menter, Riham Katkhuda, Ignacio I Wistuba, Jennifer S Davis, Scott Kopetz, Dipen Maheshbhai Maru
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)
Jennifer B Goldstein, Li Zhao, Xuemei Wang, Yael Ghelman, Michael James Overman, Milind M Javle, Rachna T Shroff, Gauri R Varadhachary, Robert A Wolff, Florencia McAllister, Andrew Futreal, David R Fogelman
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)
Jason A Willis, Michael James Overman, Eduardo Vilar
Mismatch Repair-Proficient Colorectal Cancer: Finding the Right TiME to Respond. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (17) (2019)
Liana Adam, F Anthony San Lucas, Richard Fowler, Yao Yu, Wenhui Wu, Yulun Liu, Huamin Wang, David Menter, Michael T Tetzlaff, Joe Ensor, Ganiraju Manyam, Stefan T Arold, Chad Huff, Scott Kopetz, Paul Scheet, Michael James Overman
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (2) (2018)
Christine M O'Keefe, Thomas R Pisanic, Helena Zec, Michael James Overman, James G Herman, Tza-Huei Wang
Facile profiling of molecular heterogeneity by microfluidic digital melt. Science advances 4 (9) (2018)
Victoria J Serpas, Kanwal P Raghav, Daniel M Halperin, James Yao, Michael James Overman
Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology. BMC medical research methodology 18 (1) (2018)